Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

$0.50 is highly unrealistic by summer. I could see us getting to 0.20's IF we get ANDA approved AND sales start actually taking place. Having an approved drug is good. Having sales in crowded markets is another. Situation will also depend on new SequestOx formulation outcome. If Puracap moves forward with a deal it is a good sign, not for sure a done deal w/ FDA (nothing is), but very positive for sure to help get pipeline cooking.

My honest fear is that any upfront payment(s) we receive will fund part of R&D. ANDA sales will take a while to ramp. I worry ramp will be too slow to keep funding at pace that we may be going down, bottlenecking the pipeline.

This cc was ok. Looking back 2015 was a setup year for SequestOx. Then it moved to 2016 & now 2018. Good thing out of the continual delays is that Elite is setting up for far more than just one drug. SequestOx is still the blockbuster, but now there is potentially much more coming on board later this year. And we sure as heck better have a sales & marketing agreement in place if/when an ANDA is approved.

In the end, I believe stock will be stuck for few months and start to move north in the summer and from there won't retreat.